IRISanRaf

PICCONI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.573
AS - Asia 2.609
EU - Europa 768
SA - Sud America 272
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 50
OC - Oceania 15
Totale 7.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.151
TR - Turchia 945
SG - Singapore 795
CN - Cina 615
CA - Canada 399
IT - Italia 314
BR - Brasile 236
CZ - Repubblica Ceca 119
DE - Germania 87
VN - Vietnam 86
GB - Regno Unito 69
EU - Europa 67
IE - Irlanda 45
IN - India 40
HK - Hong Kong 28
BD - Bangladesh 20
ZA - Sudafrica 20
JP - Giappone 19
FI - Finlandia 18
RU - Federazione Russa 18
MX - Messico 16
NL - Olanda 15
FR - Francia 14
ES - Italia 13
UA - Ucraina 12
AR - Argentina 10
EC - Ecuador 10
RO - Romania 10
ID - Indonesia 9
AU - Australia 8
SE - Svezia 8
CO - Colombia 6
DK - Danimarca 6
NZ - Nuova Zelanda 6
SC - Seychelles 6
TW - Taiwan 6
EG - Egitto 5
MA - Marocco 5
PK - Pakistan 5
JO - Giordania 4
KR - Corea 4
PL - Polonia 4
PS - Palestinian Territory 4
BE - Belgio 3
CL - Cile 3
DZ - Algeria 3
IL - Israele 3
IQ - Iraq 3
KE - Kenya 3
NI - Nicaragua 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
GR - Grecia 2
IR - Iran 2
LK - Sri Lanka 2
LT - Lituania 2
NG - Nigeria 2
PE - Perù 2
PH - Filippine 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DJ - Gibuti 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LB - Libano 1
LY - Libia 1
MG - Madagascar 1
MN - Mongolia 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
WS - Samoa 1
Totale 7.354
Salva come PNG Salva come JPEG
Città #
Kocaeli 807
San Mateo 688
Toronto 373
Dallas 277
Wilmington 202
Houston 181
Ashburn 176
Rome 174
Singapore 164
Chandler 159
Santa Clara 159
Lawrence 139
Princeton 139
Beijing 136
Olomouc 119
Fairfield 84
Shanghai 59
Seattle 50
Woodbridge 48
Los Angeles 42
Guangzhou 37
Munich 35
Redwood City 34
Ho Chi Minh City 28
Hong Kong 28
São Paulo 27
The Dalles 25
Dublin 23
Shenzhen 23
Cambridge 22
Brooklyn 21
Columbus 21
Hanoi 21
Chicago 19
Falls Church 19
New York 19
Tokyo 16
Jiaxing 15
Johannesburg 14
Helsinki 13
Frankfurt am Main 12
London 12
Council Bluffs 11
Wuhan 11
Belo Horizonte 10
Chennai 10
Constanta 10
Pune 10
Boston 9
Mexico City 8
Stockholm 8
Guayaquil 7
Montreal 7
Rio de Janeiro 7
Rui'an 7
Charlotte 6
Dongyang 6
Wuxi 6
Bristol 5
Dhaka 5
Haining 5
Haiphong 5
Jakarta 5
Padova 5
Phoenix 5
Saint Louis 5
Washington 5
Amman 4
Ankara 4
Atlanta 4
Boardman 4
Curitiba 4
Espoo 4
Florence 4
Genoa 4
Joinville 4
Manaus 4
Nanjing 4
Poplar 4
Quanzhou 4
Redmond 4
San Francisco 4
Shaoxing 4
Taipei 4
Trento 4
Warsaw 4
Xi'an 4
Amsterdam 3
Bismarck 3
Bogotá 3
Brasília 3
Buffalo 3
Cagliari 3
Campinas 3
Chapadinha 3
Da Nang 3
Franz Josef 3
Guarulhos 3
Hangzhou 3
Istanbul 3
Totale 4.957
Salva come PNG Salva come JPEG
Nome #
Direct and indirect pathways of basal ganglia: a critical reappraisal 196
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 147
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation 101
Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons 93
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 92
Corrigendum: Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons 83
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions. 83
Quantal release of dopamine and action potential firing detected in midbrain neurons by multifunctional diamond-based microarrays 83
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 77
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease 75
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. 71
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior 71
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuo-spatial memory alteration. 68
Dopamine drives binge-like consumption of a palatable food in experimental parkinsonism. 65
Motor Complications in Parkinson's Disease: Striatal Molecular and Electrophysiological Mechanisms of Dyskinesias 64
Synaptic dysfunction in Parkinson's disease 63
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 63
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. 62
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease 62
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 62
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 62
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 61
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 60
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 59
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 59
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease 59
Theta-burst stimulation and striatal plasticity in experimental parkinsonism 58
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 58
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 58
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission 58
NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology 58
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 57
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 57
Dopaminergic control of synaptic plasticity in the dorsal striatum 56
Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine 56
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 56
Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities 56
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias 56
Interaction between basal ganglia and limbic circuits in learning and memory processes 55
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. 55
Striatal spreading depolarization: possible implication in L-DOPA-induced dyskinetic like-behavior. 55
Early Synaptic Dysfunction in Parkinson's Disease: Insights From Animal Models 55
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 54
Role of tonically-active neurons in the control of striatal function: Cellular mechanisms and behavioral correlates 54
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia 54
N-Methyl-D-aspartate (NMDA) Receptor Composition Modulates Dendritic Spine Morphology in Striatal Medium Spiny Neurons 54
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D-2/A(2A) Receptor Interaction in the Striatum: Implications for Parkinson's Disease 54
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 53
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment 53
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate 1-DOPA-induced dyskinesia 53
Striatum-hippocampus balance: From physiological behavior to interneuronal pathology 51
New Synaptic and Molecular Targets for Neuroprotection in Parkinson's Disease 51
Neural networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 51
Serotonin drives striatal synaptic plasticity in a sex-related manner 51
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion 51
Tissue plasminogen activator is required for corticostriatal long-term potentiation 50
Rhes-mTORC1 interaction: A new possible therapeutic target in Parkinson's disease and L-dopa-induced dyskinesia? 50
Mechanisms underlying altered striatal synaptic plasticity in old A53T-alpha synuclein overexpressing mice 50
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 50
Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons 50
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. 50
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 50
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 49
Mechanisms underlying dopaminergic control of cortico-striatal synaptic transmission 49
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. 49
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 49
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 49
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 49
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 49
Prenatal stress and hippocampal BDNF expression: a fading imperative 49
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 49
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice 48
Dopamine-mediated regulation of corticostriatal synaptic plasticity. 48
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 48
NR2B subunit exerts a critical role in postischemic synaptic plasticity. 47
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP 47
Stimulation of D1/PKA/DARPP-32/PP-1 pathway is required for corticostriatal LTD and LTP 47
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia 46
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia 46
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease 46
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 46
Unilateral dopamine denervation blocks corticostriatal LTP 45
Molecular mechanisms underlying levodopa-induced dyskinesia. 45
Plastic abnormalities in experimental Huntington's disease 45
Targeting Metabotropic Glutamate Receptors as a New Strategy Against Levodopa-Induced Dyskinesia in Parkinson's Disease? 45
Hyperkinetic disorders and loss of synaptic downscaling 45
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. 45
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease 45
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of L-Dopa-induced dyskinesia 44
Basic mechanisms of plasticity and learning 44
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. 44
FUNCTIONAL INTERACTIONS WITHIN STRIATAL MICROCIRCUIT IN ANIMAL MODELS OF HUNTINGTON'S DISEASE 44
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 44
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 44
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 44
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity 44
NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients 44
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 44
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 44
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity 44
Totale 5.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.115
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.127 0 0 0 0 0 92 70 22 35 48 807 53
2021/20221.349 11 369 372 1 9 12 89 139 36 279 11 21
2022/2023647 308 15 13 54 33 16 5 21 29 63 82 8
2023/2024571 0 2 17 127 26 17 15 37 3 21 70 236
2024/20251.466 54 338 98 68 92 234 41 98 191 20 58 174
2025/20261.585 258 244 298 236 231 318 0 0 0 0 0 0
Totale 7.604